Annual Total Long Term Liabilities
$2.11 B
-$49.29 M-2.29%
December 31, 2024
Summary
- As of March 13, 2025, IONS annual total long term liabilities is $2.11 billion, with the most recent change of -$49.29 million (-2.29%) on December 31, 2024.
- During the last 3 years, IONS annual total long term liabilities has risen by +$506.60 million (+31.67%).
- IONS annual total long term liabilities is now -2.29% below its all-time high of $2.16 billion, reached on December 31, 2023.
Performance
IONS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.11 B
-$8.06 M-0.38%
December 31, 2024
Summary
- As of March 13, 2025, IONS quarterly total long term liabilities is $2.11 billion, with the most recent change of -$8.06 million (-0.38%) on December 31, 2024.
- Over the past year, IONS quarterly long term liabilities has dropped by -$49.29 million (-2.29%).
- IONS quarterly long term liabilities is now -6.60% below its all-time high of $2.25 billion, reached on June 30, 2023.
Performance
IONS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IONS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | -2.3% |
| 3 y3 years | +31.7% | -4.9% |
| 5 y5 years | +65.1% | -4.9% |
IONS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.3% | +31.7% | -6.6% | +36.4% |
| 5 y | 5-year | -2.3% | +101.0% | -6.6% | +101.0% |
| alltime | all time | -2.3% | >+9999.0% | -6.6% | >+9999.0% |
Ionis Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.11 B(-2.3%) | $2.11 B(-0.4%) |
| Sep 2024 | - | $2.11 B(-0.3%) |
| Jun 2024 | - | $2.12 B(-0.9%) |
| Mar 2024 | - | $2.14 B(-0.7%) |
| Dec 2023 | $2.16 B(+30.7%) | $2.16 B(-2.7%) |
| Sep 2023 | - | $2.21 B(-1.8%) |
| Jun 2023 | - | $2.25 B(+5.4%) |
| Mar 2023 | - | $2.14 B(+29.7%) |
| Dec 2022 | $1.65 B(+3.1%) | $1.65 B(+6.8%) |
| Sep 2022 | - | $1.54 B(-1.2%) |
| Jun 2022 | - | $1.56 B(-1.1%) |
| Mar 2022 | - | $1.58 B(-1.1%) |
| Dec 2021 | $1.60 B(+52.7%) | $1.60 B(-0.3%) |
| Sep 2021 | - | $1.60 B(-1.0%) |
| Jun 2021 | - | $1.62 B(+27.3%) |
| Mar 2021 | - | $1.27 B(+21.5%) |
| Dec 2020 | $1.05 B(-17.9%) | $1.05 B(-15.8%) |
| Sep 2020 | - | $1.24 B(-0.6%) |
| Jun 2020 | - | $1.25 B(-0.8%) |
| Mar 2020 | - | $1.26 B(-1.0%) |
| Dec 2019 | $1.28 B(+6.3%) | $1.28 B(+9.5%) |
| Sep 2019 | - | $1.17 B(-1.2%) |
| Jun 2019 | - | $1.18 B(-1.4%) |
| Mar 2019 | - | $1.20 B(-0.4%) |
| Dec 2018 | $1.20 B(+68.1%) | $1.20 B(+4.6%) |
| Sep 2018 | - | $1.15 B(-2.9%) |
| Jun 2018 | - | $1.18 B(+68.8%) |
| Mar 2018 | - | $699.82 M(-2.0%) |
| Dec 2017 | $713.88 M(+5.1%) | $713.88 M(+5.4%) |
| Sep 2017 | - | $677.25 M(-0.9%) |
| Jun 2017 | - | $683.50 M(-4.0%) |
| Mar 2017 | - | $711.61 M(+4.8%) |
| Dec 2016 | $679.12 M(+13.5%) | $679.12 M(+13.7%) |
| Sep 2016 | - | $597.05 M(+1.4%) |
| Jun 2016 | - | $588.82 M(-0.7%) |
| Mar 2016 | - | $593.16 M(-0.8%) |
| Dec 2015 | $598.23 M(+2.7%) | $598.23 M(-3.6%) |
| Sep 2015 | - | $620.39 M(+8.1%) |
| Jun 2015 | - | $573.81 M(-0.9%) |
| Mar 2015 | - | $579.29 M(-0.6%) |
| Dec 2014 | $582.70 M(+57.1%) | $582.70 M(+70.5%) |
| Sep 2014 | - | $341.71 M(-2.4%) |
| Jun 2014 | - | $350.10 M(-2.7%) |
| Mar 2014 | - | $359.68 M(-3.0%) |
| Dec 2013 | $370.95 M(+28.5%) | $370.95 M(-1.7%) |
| Sep 2013 | - | $377.19 M(+25.5%) |
| Jun 2013 | - | $300.57 M(+6.7%) |
| Mar 2013 | - | $281.57 M(-2.4%) |
| Dec 2012 | $288.60 M(+21.6%) | $288.60 M(+9.4%) |
| Sep 2012 | - | $263.80 M(+0.3%) |
| Jun 2012 | - | $263.02 M(+1.9%) |
| Mar 2012 | - | $258.23 M(+8.8%) |
| Dec 2011 | $237.35 M(+18.6%) | $237.35 M(+0.8%) |
| Sep 2011 | - | $235.42 M(+4.5%) |
| Jun 2011 | - | $225.38 M(+22.6%) |
| Mar 2011 | - | $183.84 M(-8.1%) |
| Dec 2010 | $200.04 M(-17.9%) | $200.04 M(-9.6%) |
| Sep 2010 | - | $221.23 M(-7.4%) |
| Jun 2010 | - | $238.91 M(+7.0%) |
| Mar 2010 | - | $223.19 M(-8.4%) |
| Dec 2009 | $243.68 M(-29.4%) | $243.68 M(-6.7%) |
| Sep 2009 | - | $261.03 M(-5.2%) |
| Jun 2009 | - | $275.48 M(-3.5%) |
| Mar 2009 | - | $285.38 M(-17.3%) |
| Dec 2008 | $345.20 M(+85.2%) | $345.20 M(-3.9%) |
| Sep 2008 | - | $359.26 M(-6.0%) |
| Jun 2008 | - | $382.12 M(+54.3%) |
| Mar 2008 | - | $247.69 M(+32.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $186.41 M(+40.3%) | $186.41 M(+7.8%) |
| Sep 2007 | - | $172.85 M(-1.7%) |
| Jun 2007 | - | $175.86 M(+4.3%) |
| Mar 2007 | - | $168.53 M(+26.8%) |
| Dec 2006 | $132.87 M(-5.0%) | $132.87 M(-1.4%) |
| Sep 2006 | - | $134.74 M(-1.1%) |
| Jun 2006 | - | $136.17 M(-1.3%) |
| Mar 2006 | - | $137.94 M(-1.4%) |
| Dec 2005 | $139.91 M(-41.0%) | $139.91 M(-6.4%) |
| Sep 2005 | - | $149.44 M(-38.9%) |
| Jun 2005 | - | $244.66 M(+0.4%) |
| Mar 2005 | - | $243.74 M(+2.8%) |
| Dec 2004 | $237.14 M(+6.7%) | $237.14 M(+3.1%) |
| Sep 2004 | - | $230.01 M(+1.7%) |
| Jun 2004 | - | $226.22 M(+0.3%) |
| Mar 2004 | - | $225.53 M(+1.5%) |
| Dec 2003 | $222.21 M(+7.2%) | $222.21 M(+10.9%) |
| Sep 2003 | - | $200.39 M(-1.2%) |
| Jun 2003 | - | $202.81 M(-5.1%) |
| Mar 2003 | - | $213.66 M(+3.1%) |
| Dec 2002 | $207.26 M(+42.2%) | $207.26 M(+6.3%) |
| Sep 2002 | - | $195.06 M(-6.9%) |
| Jun 2002 | - | $209.56 M(+37.5%) |
| Mar 2002 | - | $152.40 M(+4.6%) |
| Dec 2001 | $145.72 M(+42.5%) | $145.72 M(+4.1%) |
| Sep 2001 | - | $139.93 M(+21.0%) |
| Jun 2001 | - | $115.67 M(+10.7%) |
| Mar 2001 | - | $104.45 M(+2.2%) |
| Dec 2000 | $102.25 M(+17.1%) | $102.25 M(+6.1%) |
| Sep 2000 | - | $96.33 M(+1.9%) |
| Jun 2000 | - | $94.50 M(+3.5%) |
| Mar 2000 | - | $91.30 M(+4.6%) |
| Dec 1999 | $87.31 M(+12.2%) | $87.31 M(+1.8%) |
| Sep 1999 | - | $85.80 M(+4.3%) |
| Jun 1999 | - | $82.30 M(+4.2%) |
| Mar 1999 | - | $79.00 M(+1.5%) |
| Dec 1998 | $77.80 M(+37.9%) | $77.80 M(+5.3%) |
| Sep 1998 | - | $73.90 M(+2.8%) |
| Jun 1998 | - | $71.90 M(+26.8%) |
| Mar 1998 | - | $56.70 M(+0.5%) |
| Dec 1997 | $56.40 M(+184.8%) | $56.40 M(+65.4%) |
| Sep 1997 | - | $34.10 M(+1.5%) |
| Jun 1997 | - | $33.60 M(+69.7%) |
| Mar 1997 | - | $19.80 M(0.0%) |
| Dec 1996 | $19.80 M(+321.3%) | $19.80 M(+296.0%) |
| Sep 1996 | - | $5.00 M(+2.0%) |
| Jun 1996 | - | $4.90 M(-7.5%) |
| Mar 1996 | - | $5.30 M(+12.8%) |
| Dec 1995 | $4.70 M(-49.5%) | $4.70 M(-41.3%) |
| Sep 1995 | - | $8.00 M(-5.9%) |
| Jun 1995 | - | $8.50 M(-4.5%) |
| Mar 1995 | - | $8.90 M(-4.3%) |
| Dec 1994 | $9.30 M(+5.7%) | $9.30 M(-3.1%) |
| Sep 1994 | - | $9.60 M(+21.5%) |
| Jun 1994 | - | $7.90 M(-4.8%) |
| Mar 1994 | - | $8.30 M(-5.7%) |
| Dec 1993 | $8.80 M(+31.3%) | $8.80 M(+7.3%) |
| Sep 1993 | - | $8.20 M(+15.5%) |
| Jun 1993 | - | $7.10 M(+6.0%) |
| Mar 1993 | - | $6.70 M(0.0%) |
| Dec 1992 | $6.70 M(-6.9%) | $6.70 M(-5.6%) |
| Sep 1992 | - | $7.10 M(-6.6%) |
| Jun 1992 | - | $7.60 M(+5.6%) |
| Mar 1992 | - | $7.20 M(0.0%) |
| Dec 1991 | $7.20 M(+554.5%) | $7.20 M(+60.0%) |
| Sep 1991 | - | $4.50 M(-2.2%) |
| Jun 1991 | - | $4.60 M(+35.3%) |
| Mar 1991 | - | $3.40 M(+209.1%) |
| Dec 1990 | $1.10 M | $1.10 M |
FAQ
- What is Ionis Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Ionis Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Ionis Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of IONS is $2.11 B
What is the all time high annual total long term liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual total long term liabilities is $2.16 B
What is Ionis Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, IONS annual total long term liabilities has changed by -$49.29 M (-2.29%)
What is Ionis Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of IONS is $2.11 B
What is the all time high quarterly long term liabilities for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly total long term liabilities is $2.25 B
What is Ionis Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, IONS quarterly total long term liabilities has changed by -$49.29 M (-2.29%)